| HIB | heart infusion broth; hemolytic immune body; Hemophilus influenzae type B [vaccine] |
|---|---|
| HPV | Hemophilus pertussis vaccine; hepatic portal vein; human papillomavirus; human parvovirus; hypoxic p... |
| IBV | infectious bronchitis vaccine; infectious bronchitis virus |
| IDT | immune diffusion test; instillation delivery time; intradermal typhoid [vaccine] |
| IPV | inactivated poliomyelitis vaccine or virus; infectious pustular vaginitis; infectious pustular vulvo... |
| WKY | Wistar Kyoto strain |
|---|---|
| D7 | diploid strain |
| S | strain |
| SRB51 | strain RB51 |
| typhus vaccine | A formaldehyde-inactivated suspension of Rickettsia prowazekii grown in embryonated eggs; effective against louse-borne (epidemic) typhus; primary immunization consists of two subcutaneous injections 4 or more weeks apart; booster doses are required every 6 to 12 months, as long as the possibility of exposure exists. A vaccine containing living rickettsiae of an attenuated strain of R. Prowazekii has also been used. (05 Mar 2000) |
|---|---|
| yellow fever vaccine | A living, attenuated strain (17D) of yellow fever virus propagated in embryonated fowl eggs. A suspension of dried mouse brain infected with French neurotropic (Dakar) strain of yellow fever virus, administered topically by the scratch method; not officially recommended in the United States because of meningoencephalitic reactions. (05 Mar 2000) |
| flu vaccine | The flu (influenza) vaccine is recommended for persons at high risk for serious complications from influenza infection, including everyone 65 or over; people with chronic diseases of the heart, lung or kidneys, diabetes, immunosuppression, or severe forms of anaemia; residents of nursing homes and other chronic-care facilities, children and teenagers on long-term aspirin therapy (and who may therefore be at risk for developing Reye syndrome after an influenza infection), and those in close or frequent contact with anyone at high risk. Persons with an allergy to eggs should not receive influenza vaccine. (12 Dec 1998) |
| live oral poliovirus vaccine | Inactivated poliovirus vaccine (IPV), an aqueous suspension of inactivated strains of poliomyelitis virus (types 1, 2, and 3) used by injection; has largely been replaced by the oral vaccine. See: Salk vaccine. (05 Mar 2000) |
| live vaccine | Vaccine prepared from living, attenuated organisms. (05 Mar 2000) |
| low-egg-passage vaccine | See: rabies vaccine, Flury strain egg-passage. (05 Mar 2000) |